Nefazodone Hydrochloride
Product Images NDC 21695-177

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nefazodone Hydrochloride (NDC 21695-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (4afee435 Ae60 4260 A1df E52abf7a043d 01)

FDA Label Image

Nefazodone HCl 100mg (4afee435 Ae60 4260 A1df E52abf7a043d 02)

FDA Label Image

Nefazodone HCl 150mg (4afee435 Ae60 4260 A1df E52abf7a043d 03)

This is a description of Nefazodone HCI 150mg tablets. Each tablet contains 150mg of the active ingredient NCTRZOTONE. The product is manufactured by Teva Pharmaceuticals and has a product ID of RN017560. The tablets should be stored in a controlled room temperature of 15-30°C and should be kept out of the reach of children.*

FDA Label Image

Nefazodone HCl 200mg (4afee435 Ae60 4260 A1df E52abf7a043d 04)

FDA Label Image

Nefazodone HCl 200mg (4afee435 Ae60 4260 A1df E52abf7a043d 05)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.